Small Bowel Obstruction – Adhesive, Non-Malignant Obstruction

Original Date: 09/2026

Objective: To standardize the care of patients with adhesive small bowel obstruction

This study applies to patients with symptomatic bowel obstruction assumed to be of adhesive origin. Patients with obstructions due to hernia(abdominal wall or internal), malignancy, volvulus, IBD, stricture, or other non-adhesive etiologies are not covered by this guideline. Patients who are post op Roux-en-Y gastric bypass represent a separate, high-risk entity and are likely not covered by this guideline.

Summary Statement: Small bowel obstruction (SBO) is one of the most common complications encountered by general surgeons. Despite this, significant variability in care exists. The most common cause of SBO is adhesive disease, usually from previous surgery or infection, and is managed conservatively. Recent literature has elucidated risk factors for failure of conservative management, and techniques to expedite decision making and care in these patients to avoid prolonging hospital stay.

Diagnosis: CT scan with IV contrast should be performed in all patients presenting with symptoms consistent with SBO unless immediate operative management is indicated.

PO contrast for CT is not routinely necessary

The following constitute HIGH RISK features in patients with SBO. Consider immediate operative management in the following situations:

Clinical:

Guarding/Peritonitis
Hemodynamic Instability
Severe lactic acidosis

Imaging:

Reduced bowel wall enhancement or thickening,
Mesenteric venous congestion or fluid,
Abdominal Free Fluid
Abnormal path of mesenteric vasculature course (whorl sign),
Closed loop obstruction – multiple transition points

Risk stratification models are available for prediction of non-operative management, and for prediction of strangulation:

STRISK-NOFA | Predicting need for surgical intervention in small bowel obstruction (external link)

***Operative intervention should not be delayed for contrast challenge in cases with high risk features.

Management:

Patients with complete/high grade SBO (defined as symptomatic obstipation with imaging findings consistent with small bowel obstruction) should be admitted to the general surgery, and are addressed in this guideline. (Patient diagnosed with partial small bowel obstruction(ie: radiographic signs of obstruction without obstipation or constipation, mild or no symptoms), or malignant obstruction not deemed to be a surgical candidate may be admitted to the medicine service and are not addressed here).

Principles of Management

Initial Management:

NG tube decompression, low intermittent suction. Order x-ray to confirm NG positioning
NPO status,
IV resuscitation (as appropriate) with maintenance fluid. (Plasmalyte, Ringers Lactate as initial resuscitation, consider D5 containing fluid once resuscitated)
Repletion of electrolytes
Strict ins and outs – Foley catheter not mandatory, but consider in cases of severe AKI

Routine use of antibiotics is not recommended.

Contrast Study:

The use of contrast studies has been associated with decreased length of stay, faster resolution of obstruction, and more rapid time to OR. All patients admitted with SBO should undergo a contrast study within 24 hours of admission.

Contrast study instructions:

Patients undergo at least 2 hours of NG tube decompression, with correction of electrolyte abnormalities
A baseline KUB and pelvic view x-ray is taken prior to contrast administration. This will be performed by radiology at the time of contrast administration. Please call radiology once ready for this test, and the baseline KUB/pelvic views can be taken just prior to administration of contrast. A second film will be taken immediately after administration.
100mL of water soluble enteral contrast (omnipaque) given PO/via NG followed by NG clamp. Enteral contrast not to be diluted prior to administration
Vomiting consists of a failure of a contrast study, and the NG should be placed back to suction. NG tubes should not remain clamped overnight. The NG tube can be placed back to suction at the attending/chief resident discretion, but should remain clamped for at minimum 2 hours after contrast administration.
Abdominal x-ray (KUB + pelvic views) will be performed at 8 hours and 24 hours.
Failure of contrast to progress to the colon at 24 hours predicts failure of non-operative management

If contrast has passed into the colon, NG may be removed at the discretion of the attending provider followed by initiation of diet. The decision on type of diet is also at the discretion of the attending provider.

Contrast passage to the colon has a positive predictive value of 98% for resolution of adhesive SBO.

Failure of contrast to progress predicts failure of non-operative management. Patients should be considered for operative management if contrast has failed to progress to the colon. The decision to operate should be individualized based on individual risk assessment and operative factors, and failure of a contrast passage at 24 hours does not necessarily mandate exploration. The decision should be individualized and discussed with the patient.

Failure to pass contrast at 48-72 hours has an even higher prediction for non-operative management, and operative exploration should be strongly considered in these cases.

NG Clamping

NG clamping trials may be selectively used in cases where the trajectory of the obstruction is unclear, or if outputs are high despite suspicion of resolution. There is very little evidence around length of time of clamping, or cutoffs for residuals. If employed, NG tubes should not be clamped overnight, or in patients who may not be able to report nausea/vomiting, or in whom airway protection is questionable.

Contrast Study:

Contrast study instructions:

Patients undergo at least 2 hours of NG tube decompression, with correction of electrolyte abnormalities
A baseline KUB and pelvic view x-ray is taken prior to contrast administration. This will be performed by radiology at the time of contrast administration. Please call radiology once ready for this test, and the baseline KUB/pelvic views can be taken just prior to administration of contrast. A second film will be taken immediately after administration.
100mL of water soluble enteral contrast (omnipaque) given PO/via NG followed by NG clamp. Enteral contrast not to be diluted prior to administration
Vomiting consists of a failure of a contrast study, and the NG should be placed back to suction. NG tubes should not remain clamped overnight. The NG tube can be placed back to suction at the attending/chief resident discretion, but should remain clamped for at minimum 2 hours after contrast administration.
Abdominal x-ray (KUB + pelvic views) will be performed at 8 hours and 24 hours.
Failure of contrast to progress to the colon at 24 hours predicts failure of non-operative management

Contrast passage to the colon has a positive predictive value of 98% for resolution of adhesive SBO.

Failure to pass contrast at 48-72 hours has an even higher prediction for non-operative management, and operative exploration should be strongly considered in these cases.

NG Clamping

NG clamping trials may be selectively used in cases where the trajectory of the obstruction is unclear, or if outputs are high despite suspicion of resolution. There is very little evidence around length of time of clamping, or cutoffs for residuals. If employed, NG tubes should not be clamped overnight, or in patients who may not be able to report nausea/vomiting, or in whom airway protection is questionable.

Operative Management

Decisions on approach should be individualized to the patient’s history and attending level of comfort. Minimally invasive lysis of adhesions is associated with shorter length of stay and decreased morbidity, however hemodynamic instability, significant abdominal distention, and underlying comorbidities may preclude minimally invasive approaches.

References

Baghdadi YMK, Choudhry AJ, Goussous N, Khasawneh MA, Polites SF, Zielinski MD. Long-term outcomes of gastrografin in small bowel obstruction. J Surg Res 2016; 202: 43–8. doi: 10.1016/j.jss.2015.11.017 [DOI (external link)] [PMC free article (external link)] [PubMed (external link)] [Google Scholar (external link)]
Goussous N, Eiken PW, Bannon MP, Zielinski MD. Enhancement of a small bowel obstruction model using the gastrografin® challenge test. J Gastrointest Surg 2013; 17: 110–7. doi: 10.1007/s11605-012-2011-6 [DOI (external link)] [PubMed (external link)] [Google Scholar (external link)]
Zielinski MD, Eiken PW, Heller SF, Lohse CM, Huebner M, Sarr MG, et al. Prospective, observational validation of a multivariate small-bowel obstruction model to predict the need for operative intervention. J Am Coll Surg 2011; 212: 1068–76. doi: 10.1016/j.jamcollsurg.2011.02.023 [DOI (external link)] [PubMed (external link)] [Google Scholar (external link)]
Zielinski MD, Haddad NN, Cullinane DC, Inaba K, Yeh DD, Wydo S, et al. Multi-institutional, prospective, observational study comparing the Gastrografin challenge versus standard treatment in adhesive small bowel obstruction. J Trauma Acute Care Surg 2017; 83: 47–54. doi: 10.1097/TA.0000000000001499 [DOI (external link)] [PubMed (external link)] [Google Scholar (external link)]
Branco BC, Barmparas G, Schnüriger B, Inaba K, Chan LS, Demetriades D. Systematic review and meta-analysis of the diagnostic and therapeutic role of water-soluble contrast agent in adhesive small bowel obstruction. Br J Surg 2010; 97: 470–8. doi: 10.1002/bjs.7019 [DOI (external link)] [PubMed (external link)] [Google Scholar (external link)]
Ceresoli M, Coccolini F, Catena F, Montori G, Di Saverio S, Sartelli M, et al. Water-soluble contrast agent in adhesive small bowel obstruction: a systematic review and meta-analysis of diagnostic and therapeutic value. Am J Surg 2016; 211: 1114–25. doi: 10.1016/j.amjsurg.2015.06.012 [DOI (external link)] [PubMed (external link)] [Google Scholar (external link)]